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Abstract Further knowledge about the clinical and microbi-
ological characteristics of prosthetic joint infections (PJIs)
caused by different coagulase-negative staphylococci
(CoNS) may facilitate interpretation of microbiological find-
ings and improve treatment algorithms. Staphylococcus
capitis is a CoNS with documented potential for both human
disease and nosocomial spread. As data on orthopaedic infec-
tions are scarce, our aim was to describe the clinical and mi-
crobiological characteristics of PJIs caused by S. capitis. This
retrospective cohort study included three centres and 21 pa-
tients with significant growth of S. capitis during revision
surgery for PJI between 2005 and 2014. Clinical data were
extracted and further microbiological characterisation of the
S. capitis isolates was performed. Multidrug-resistant (≥3 an-
tibiotic groups) S. capitis was detected in 28.6 % of isolates,
methicillin resistance in 38.1 % and fluoroquinolone resis-
tance in 14.3 %; no isolates were rifampin-resistant.
Heterogeneous glycopeptide-intermediate resistance was de-
tected in 38.1 %. Biofilm-forming ability was common. All
episodes were either early post-interventional or chronic, and
there were no haematogenous infections. Ten patients experi-
enced monomicrobial infections. Among patients available
for evaluation, 86 % of chronic infections and 70 % of early
post-interventional infections achieved clinical cure; 90 % of
monomicrobial infections remained infection-free. Genetic
fingerprinting with repetitive sequence-based polymerase
chain reaction (rep-PCR; DiversiLab®) displayed clustering
of isolates, suggesting that nosocomial spread might be pres-
ent. Staphylococcus capitis has the potential to cause PJIs,
with infection most likely being contracted during surgery or
in the early postoperative period. As S. capitis might be an
emerging nosocomial pathogen, surveillance of the preva-
lence of PJIs caused by S. capitis could be recommended.
Introduction
Staphylococcus spp. are the most common cause of prosthetic
joint infections (PJIs). In different series, coagulase-negative
staphylococci (CoNS) occur in 13–41 % of infections [1].
Previous routine practice has usually been to identify
S. epidermidis and S. lugdunensis to the species level but
report all others to the clinician as CoNS. This might pose a
particular problem for PJIs, as case definitions include growth
of low-virulence pathogens (i.e. CoNS) in ≥2 perioperative
tissue samples [2, 3]. Thus, it might make a difference if two
isolated CoNS belong to the same species (indicating infec-
tion) or two different species (indicating contamination).
Differences in antibiotic resistance patterns are used in the
attempt to distinguish between different CoNS species [4],
but no data support this practice in diagnosing PJIs.
However, the implementation of new methods, such as
matrix-assisted laser desorption/ionisation time-of-flight mass
spectrometry (MALDI-TOFMS) or real-time broad-range po-
lymerase chain reaction (PCR), has simplified the identifica-
tion of CoNS to the species level [5, 6]. This might contribute
to better understanding of the epidemiology and pathogenicity
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of these bacteria in PJIs, as the CoNS act as both pathogens
and commensals [7].
Staphylococcus capitis is a CoNS mainly distributed on
the head (primarily ears and forehead), arms and occasion-
ally legs. A previous study showed that 20 % of individuals
maintained persistent populations on the head and arms
over 1 year [8].
Staphylococcus capitis has two subspecies: subsp.
urealyticus and subsp. capitis. The former, but not the latter,
has been shown to increase its range of habitats outside the
head during antibiotic therapy.
Both subspecies are classified as human pathogens [9].
Case reports indicate that S. capitis plays a role in contin-
uous ambulatory peritoneal dialysis peritonitis [10],
prosthetic-valve endocarditis [11], pacemaker endocarditis
[12], meningitis [13], acetabulum osteomyelitis [14] and
spondylodiscitis [15].
It is also a well-recognised pathogen in neonatal sepsis,
where its capacity for clonal nosocomial spread has been ver-
ified by genetic fingerprinting [16, 17]. Investigation of nine
S. capitis isolates from blood cultures in neonatal intensive
care units (NICUs) showed that all of them exhibited
vancomycin-heteroresistant subpopulations [18].
Staphylococcus capitis has only rarely been identified to
the species level in routine clinical practice, even when ob-
tained from PJIs. However, recent reports focusing on further
subtyping of bone and joint infection isolates have identified
S. capitis as a causative organism [6, 7, 19, 20], though its role
as a pathogen has been debated. Staphylococcus capitis has
also been shown to be the predominant CoNS in laminar air
flow during prosthetic joint surgery [21]. Therefore, the aim of
this retrospective cohort study was to describe the clinical and
microbiological characteristics of PJIs caused by S. capitis.
Materials and methods
Study population
The study population was recruited from three centres in cen-
tral Sweden, representing approximately one million inhabi-
tants; the county councils of Värmland (Karlstad Central
Hospital), Östergötland (Linköping University Hospital) and
Örebro (Örebro University Hospital). All patients were iden-
tified by the laboratory information systems and the presence
of CoNS in perioperative tissue biopsies retrieved from revi-
sion surgery for hip or knee PJI. As there are no private lab-
oratories processing microbiological samples in these regions,
this process will have identified all episodes of PJIs resulting
in surgery with tissue biopsies for culture.
PJI was defined according to the criteria of the Infectious
Diseases Society of America (IDSA) [2]. A total of 21 patients
diagnosed between 2005 and 2014were followed from the PJI
diagnosis until the end of the study, treatment failure or death.
Clinical cure was defined as ≥24months without recurrence of
infection after the end of treatment. In cases where clinical
cure was presumed but follow-up was ≤24 months, the result
was defined as non-available (n/a).
The study was approved by the Regional Ethical Review
Board of Uppsala (ref: 2014/418).
Bacterial isolates
CoNS isolated in ≥2 perioperative tissue samples obtained
from revision surgery for hip or knee arthroplasties due to
PJI were included for further analysis. If there were not at least
two CoNS isolates with similar colony morphology and anti-
microbial resistance pattern, the patient was excluded.
MALDI-TOF MS was performed for species identification
using a Microflex LT (Bruker Daltonik GmbH, Bremen,
Germany) and MALDI Biotyper software version 3.1
(Bruker Daltonik), with a required score threshold of ≥2.0.
Further verification was performed by rpoB sequencing of
four isolates (#R1, #R2, #12, #15) representing different clus-
ters in the DiversiLab dendrogram. All staphylococci other
than S. capitis were excluded. Polymicrobial infections,
whether caused by staphylococci or other pathogens, were
included as long as S. capitis was found in at least two tissue
cultures. To discriminate between subsp. capitis and
urealyticus, urease activity and maltose fermentation tests
were performed [22], using both tube test and ID32 STAPH
(bioMérieux, Marcy l’Etoile, France).
All isolates were stored at −70 °C at the clinical laboratory
in each county, then subcultured at 35 °C overnight on
Columbia II agar (BD Diagnostic Systems, Sparks, MD,
USA) supplemented with 6 % horse blood (SVA, Uppsala,
Sweden).
Reference isolates CCUG 55892 (S. capitis subsp.
urealyticus) and CCUG 35173 (S. capitis subsp. capitis)
were used.
Antibiotic susceptibility testing
Standard antibiotic susceptibility testing by the disc diffusion
test was performed for cefoxitin (30 μg), fusidic acid (10 μg),
erythromycin (15 μg), clindamycin (2 μg), trimethoprim/
sulphamethoxazole (25 μg), gentamicin (10 μg), norfloxacin
(10 μg), ciprofloxacin (5 μg), rifampin (5 μg) and vancomy-
cin (5 μg) (all antibiotic discs from Oxoid, Basingstoke,
Hampshire, England), with a 0.5 McFarland bacterial suspen-
sion in 0.85 % NaCl on Mueller–Hinton agar (Oxoid). After
16–20 h of incubation at 36 °C, the zone diameters were
measured and each isolate was evaluated according to
European Committee on Antimicrobial Susceptibility
Testing (EUCAST) breakpoints (http://www.eucast.org,
accessed 2015-03-20).
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Standard minimum inhibitory concentration (MIC) deter-
mination with the Etest (bioMérieux) was performed for van-
comycin and teicoplanin on Mueller–Hinton agar (Oxoid)
with a bacterial suspension adjusted to 0.5 McFarland in
0.85 % NaCl. The results were determined after 24 h of incu-
bation at 36 °C, and, again, each isolate was evaluated accord-
ing to EUCAST breakpoints.
Isolates resistant to ≥3 antibiotic groups tested were con-
sidered multidrug-resistant (MDR).
Screening for heterogeneous glycopeptide-intermediate
S. capitis
The detection of heterogeneous glycopeptide-intermediate
S. capitis (hGISC) was performed using the VAN4 method
[17, 18, 23]. Briefly, an overnight blood agar plate culture
was suspended in 0.9 % NaCl and adjusted to 0.5
McFarland turbidity. Four droplets (10 mL) of the suspension
were dropped onto a BHI agar plate (BD Diagnostic Systems)
containing 16 g/L pancreatic digest of casein (BD Diagnostic
Systems) and 4 mg/mL vancomycin. After 48 h of incubation
at 35 °C, the colonies in each droplet were counted. If ≥1
droplet had ≥2 colonies, the strain was considered to be
heteroresistant to vancomycin. In addition, the macromethod
Etest (MME) and glycopeptide resistance detection (GRD)
Etest were performed as previously described [24].
Biofilm
For the detection of biofilm production, both microtitre plate
assay (MTP) and Congo red agar assay (CRA) were used, as
previously described, with the modification of 48 h of incu-
bation at 36 °C for the CRA assay instead of 24 h [25–27].
Staphylococcus epidermidis RP62A was used as the positive
control and S. epidermidis ATCC 12228 as the negative
control.
Repetitive sequence-based PCR (DiversiLab®)
The semi-automatic repetitive sequence-based PCR (rep-
PCR) microbial genotyping system (DiversiLab®) was used
to detect the genomic fingerprints of each S. capitis isolate as
previously described [28], with the exception of using the
DiversiLab® Staphylococcus fingerprinting kit (bioMérieux,
Marcy l’Etoile, France), following the manufacturer’s
instructions.
Statistics
Version 18 of the SPSS software package (IBM SPSS,
Chicago, IL, USA) was used for data handling.
Results
Species identification
No isolates were identified as S. capitis subsp. capitis, 13
isolates (61.9 %) were identified as S. capitis subsp.
urealyticus and 8 isolates (38.6 %) were untypeable; that is,
they were urease-negative and maltose-positive despite using
two different methods. There were no divergent results be-
tween the two methods among these 21 analyses. However,
the reference isolate CCUG 55892 (S. capitis subsp
urealyticus) was not identified as subsp. urealyticus (urease-
negative/maltose-positive in tube fermentation, urease-nega-
tive/maltose-negative using ID32 STAPH).
Antimicrobial susceptibility testing
Resistance to methicillin was found in 38.1 % of isolates, to
erythromycin in 33.3 %, to clindamycin in 23.8 %, to genta-
micin in 38.1 %, to ciprofloxacin in 13.6 %, to norfloxacin in
14.3 % and to fusidic acid in 4.8 %. No isolates were resistant
to rifampin, linezolid, trimethoprim/sulphamethoxazole,
teicoplanin or vancomycin. The mean vancomycin MIC was
1.25 mg/L (range 0.75–1.25 mg/L) and the mean teicoplanin
MIC was 0.5 mg/L (range 0.094–1.0 mg/L). No isolates were
identified as hGISC under either MME or GRD Etests, while
38.1 % of isolates were hGISC according to the VAN4 meth-
od. A total of 28.6 % of isolates were MDR and among those
83.3 % were hGISC.
Biofilm formation
The two methods were not consistent in the detection of bio-
film formation in S. capitis (Fig. 1). CRA detected biofilm
formation in 71.4 % of isolates, while the MTP assay was
positive, although displaying low values of optical density
(OD), in 76.2 %. All isolates were positive in at least one of
the two methods, and 47.6 % of isolates were positive in both
methods.
Molecular epidemiology of clinical S. capitis isolates
from PJIs in a 10-year period
Using the DiversiLab® software, a dendrogram (Fig. 2) was
created to assess similarities between the isolates. The dendro-
gram showed two distinct clusters with highly divergent gel
patterns. Both reference isolates were located in the upper
cluster, even though they belonged to different subspecies.
Isolates from patients 19 and 21 were both isolated on the
same day in the same centre. Four isolates from centre 3 orig-
inating between 2009 and 2011 (6, 8, 10 and 17) were clus-
tered together in the lower cluster, as were four isolates from
centre 1 originating between 2009 and 2014 (1, 2, 3 and 15).
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Figure 3 shows a dendrogram illustrating the similarity
between three perioperative isolates obtained simultaneously
from patient 1, with the results of biochemical analysis and
antimicrobial susceptibility testing added. The dendrogram
displays close clustering between the three isolates, although
the biochemical phenotype and antimicrobial susceptibility
patterns differ.
Clinical data
The patient characteristics are outlined in Table 1. Ten of the
infections were monomicrobial and another three contained
other CoNS species in addition to S. capitis. Eleven infections
were early post-interventional (infection ≤1 month after sur-
gery), while the remaining cases were chronic infections or
were diagnosed during surgery for suspected aseptic loosen-
ing. There were no episodes of acute haematogenous
infection.
Wound healing disturbances were common in the early post-
interventional infections (Table 2), regardless of whether the in-
fection was mono- or polymicrobial. Pain was the most common
symptom among patients with chronic infections. The patients
with monomicrobial early post-interventional infections
expressed the highest levels of C-reactive protein and the patients
with monomicrobial chronic infections expressed the lowest.
All chronic infections were treated with prosthesis ex-
change surgery (six two-stage and three one-stage exchange),
except one episode diagnosed during cup revision. Clinical
cure was achieved in six of the seven assessable cases
(85.7 %). Of the early post-interventional infections, ten were
treated with debridement, antibiotics and implant retention
(DAIR) and one with two-stage exchange; seven of the ten
assessable cases (70.0 %) achieved clinical cure. All ten pa-
tients with monomicrobial S. capitis infections, except one
who unexpectedly died within the first week after surgery,
achieved clinical cure.
Discussion
This cohort study of PJIs caused by S. capitis combines clin-
ical data with microbiological characterisation of the isolates.
We present 21 cases, including ten monomicrobial infections,
where S. capitis has been isolated in ≥2 tissue samples obtain-
ed during revision surgery for PJIs, thus fulfilling the criteria
for PJI. None of the cases were acute haematogenous, sug-
gesting that the main route of transmission for S. capitis is
perioperative or early in the postoperative phase. The finding
that S. capitis is prevalent in the air of operation rooms may
further support this hypothesis [21].
To our knowledge, no previous data regarding rep-PCR
in the setting of S. capitis are available, as most work is
performed on S. aureus. However, in a recent publication
on S. caprae in bone and joint infections [29], rep-PCR
was compared to pulsed-field gel electrophoresis (PFGE),
with the conclusion that it may be a good screening meth-
od. In our analysis, there were three interesting clusters in
the dendrogram obtained with rep-PCR that warrant fur-
ther discussion. The first and second clusters included four
isolates each from two different centres (6, 8, 10 and 17
from centre 3; 1, 2, 3 and 15 from centre 1). Some of these
episodes were temporally close, with only 4 months be-
tween the primary surgery in patients 11 and 13, 5 months
between patients 5 and 11, and 8 months between patients
16 and 18. Also, four of the five isolates from centre 1
exhibited the MDR phenotype. This, combined with
knowledge from observations from NICUs [16, 17] and
bloodstream isolates [30], is suggestive of nosocomial
clonal spread of S. capitis causing PJIs.
The third cluster consisted of patients 19 and 21, whose
samples were isolated at the same centre on the same day by
the same surgeon during revision surgery for suspected chron-
ic infection. Multiple CoNS were obtained in cultures from
patient 19, with growth of S. epidermidis with two different
antibiotic susceptibility patterns in all five samples, S. capitis
in three samples and S. hominis in one. No antibiotic treatment
was given, and the patient has not requested further interven-
tion. Multiple staphylococci were also obtained in patient 21:
S. capitis in three of five samples, S. epidermidis in three and
S. aureus in one. However, during revision surgery 6 weeks
later, no bacteria were found in the tissue samples. As primary
surgery in these two patients was performed 8 years apart,
Fig. 1 Staphylococcus capitis (n = 21) isolated from prosthetic joint
infections (PJIs). The Congo red agar (CRA) results are compared to
optical density (OD) values in the microtitre plate assay (MTP) in relation
to the MTP cut-off; the CRA-negative isolates display a wide range of
OD, while the majority of CRA-positive isolates cluster close to the cut-
off
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contamination in the operating theatre seems plausible, even
though both these cases fulfil the criteria for infection. This
highlights the importance of adequate handling of samples
throughout the entire chain, from the operating theatre to the
microbiological laboratory.
Thus, some of these positive cultures might indicate contam-
ination, even though they fulfilled the criteria for PJI. Figure 3
further demonstrates the complexity in diagnosing PJIs caused
by S. capitis. This patient presented a sinus tract 17 months
after primary knee arthroplasty. Without subtyping, the clini-
cianwould probably have interpreted the finding of three CoNS
with different antimicrobial susceptibility patterns as a contam-
ination. Subtyping demonstrated that all isolates were S. capitis,
but biochemical tests differed regarding maltose fermentation
and urease activity, still suggesting polyclonal contamination.
However, rep-PCR analysis, which is not used in routine clin-
ical practice, demonstrated >98 % similarity between the iso-
lates, indicating infection despite the phenotypic divergences.
All typeable S. capitis consisted of subsp. urealyticus,
which has previously been shown to be more likely to express
biofilm in vitro, and also expresses more extensive antibiotic
resistance compared to subsp. capitis [31]. However, we dis-
covered difficulties in further distinguishing between these
two subspecies using maltose/urease biochemical tests. By
using two different methods, we tried to eliminate the possi-
bility that this phenomenon might be solely methodological.
Fig. 2 Dendrogram created with DiversiLab® including information
about centre (centre 1: n = 5, centre 2: n = 4, centre 3: n = 12), infection
type, year of isolation, i.e. diagnosis of PJI (year of primary surgery),
number of tissue cultures displaying growth of S. capitis/total number
of cultures, total number of pathogens in significant amount (≥2 tissue
cultures or ≥1 if highly pathogenic bacteria such as S. aureus), subspecies,
methicillin sensitivity (met), heterogeneous glycopeptide-intermediate
S. capitis (using the VAN4 screening method), multidrug-resistance
(MDR) and biofilm-forming ability (CRA = Congo red agar, MTP =
microtitre plate assay)
Fig. 3 Dendrogram created with DiversiLab® combined with the results
of biochemical analyses from three simultaneously collected isolates from
patient 1 during surgery. This infection was monomicrobial. U/Ma,
urease/maltose; met, methicillin; cli, clindamycin; ery, erythromycin;
nor, norfloxacin; cip, ciprofloxacin
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Other potential explanations for this include differences in
phenotypic expression or, as has been proposed earlier [19],
the presence of a novel subspecies of S. capitis.
Regarding the assays for the detection of biofilm formation,
theMTP assay generally yielded very low levels of OD, giving a
poor separation when calculating the cut-off as the mean of the
negative control +3SD. Even if the importance of the ica locus in
biofilm production of S. capitis is not clearly defined [31, 32],
future comparison of the genomes of these isolatesmight provide
further insights regarding both biofilm formation and subtype.
Outcomes were generally favourable, especially in
monomicrobial infection. There was less multidrug resistance
as well as a lower presence of glycopeptide-heteroresistant sub-
populations among these isolates compared with S. epidermidis
isolated from PJIs from the same region [24]. Regarding the
detection of glycopeptide-heteroresistant subpopulations, the
time-consuming population analysis profile/area under the curve
Table 1 Characteristics of 21 patients diagnosed with prosthetic joint
infections (PJIs) with significant growth of Staphylococcus capitis
Baseline data n = 21
Male sex 15 (71 %)
Age (years) 65.8 (24–87)
Rheumatic disorder 2 (10 %)
Diabetes mellitus 1 (5 %)
Monomicrobial infection 10 (48 %)
Joint affected
Hip 13 (62 %)
Knee 8 (38 %)
Antibiotics postoperative (final) n = 21
Vancomycin 11 (52 %)
Beta-lactam 4 (19 %)
Clindamycin 3 (14 %)
None 2 (10 %)
Daptomycin 1 (5 %)
Antibiotics follow-up (final) n = 21
Rifampin combination 10 (48 %)
Rifampin/fluoroquinolone 4 (19 %)
Rifampin/fusidic acid 4 (19 %)
Rifampin/clindamycin 1 (5 %)
Rifampin/linezolid 1 (5 %)
Surgery n = 21
DAIR 11 (52 %)
Symptom->DAIR ≤21 days 9 (82 %)
One-stage exchange 3 (14 %)
Two-stage with spacer 5 (24 %)
Two-stage without spacer 2 (10 %)
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(PAP-AUC) is regarded to be the gold standard, while reliable
screening methods are lacking. MME and GRD Etests are
methods validated for S. aureus, although a few reports are avail-
able for S. epidermidis as well [24, 33]. To our knowledge, these
methods have not been applied to S. capitis, while VAN4 has
been compared to PAP-AUC and standard Etest in a limited
number of isolates [18]. When analysing the PJI isolates present-
ed in this paper, no heteroresistant subpopulations were detected
using MME and GRD Etests, while 38.1 % of isolates were
hGISC according to VAN4. Among the MDR isolates, the prev-
alence was even higher. Since heteroresistant subpopulations
might be difficult to detect by screening methods, these results
suggest that MME and GRD Etests might be insufficient for use
in the setting of S. capitis.
In conclusion, S. capitis has the potential to cause PJIs,
both on its own and as part of polymicrobial infections.
Antibiotic susceptibility patterns are generally more
favourable compared with S. epidermidis isolated from PJIs.
It is most likely that PJI caused by S. capitis is contracted
during surgery or in the early postoperative period.
Furthermore, since fingerprinting with rep-PCR displayed
clustering within and between centres, surveillance of the
prevalence of PJIs caused by S. capitis could be recommended
in order to allow swift action if nosocomial spread occurs.
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